Pretreatment prognostic factors for survival in small-cell lung cancer: A new prognostic index and validation of three known prognostic indices on 341 patients

Annals of Oncology

Volumn 8, Issue 6, 1997, Pages 547-553

  Maestu, I ^a   Pastor, M ^a   Gomez Codina J ^a   Aparicio, J ^a   Oltra, A ^a   Herranz, C ^a   Montalar, J ^a   Munarriz B ^a   Reynes G ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Prognostic groups; Prognostic index; Small cell lung cancer; Survival

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; CANCER SURVIVAL; HUMAN; LUNG CANCER; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

EID: 0030751110     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008212826956     Document Type: Article

References (44)

1. Dearing MP, Steinberg SM, Phelps R et al. Outcome of patients with small-cell lung cancer: Effect of changes in staging procedures and imaging technology on prognostic factors over 14 years. J Clin Oncol 1990; 8: 1042-9.
2. Osterlind K. Ihde DC, Ettinger DS et al. Staging and prognostic factors in small-cell carcinoma of the lung. Cancer Treat Rep 1983; 67: 3-9.
3. Aisner J, Whitley NO. Staging of small-cell lung cancer: Do we need a new staging system? In Hansen HH, Kristjansen P (eds): Management of Small-Cell Lung Cancer. Amsterdam: Elsevier 1989: 45-54.
4. George SL. Identification and assessement of prognostic factors. Semin Oncol 1988; 15: 465-71.
5. Vincent MD, Ashley SE, Smith IE. Prognostic factors in small-cell lung cancer: A simple prognostic index is better than conventional staging. Eur J Cancer Clin Oncol 1987; 23: 1589-99.
6. Souhami RL, Bradbury I. Geddes DM et al. Prognostic significance of laboratory parameters measured at diagnosis in small-cell carcinoma of the lung. Cancer Res 1985; 45: 2878-82.
7. Souhami RL, Earl HM, Ash CM et al. Prognostic factors in patients with small-cell lung cancer: Preliminary results from a large randomised study. Antibiot Chemother 1988; 41: 77-82.
8. Cerny T, Blair V, Andersen H et al. Pretreatment prognostic-factors and scoring system in 407 small-cell lung cancer patients. Int J Cancer 1987; 39: 146-9.
9. World Health Organization. The World Health Organization histological typing of lung tumours. Am J Clin Pathol 1982; 77: 123-36.
10. Yesner R. Classification of lung cancer histology. N Engl J Med 1985; 312: 652-3.
11. Hansen H, Dombernowsky P, Hirsch F. Staging procedures and prognostic features in small cell anaplastic bronchogenic carcinoma. An in-depth analysis of prognostic factors. Semin Oncol 1978; 5: 280-7.
12. Ihde DC, Makuch RW, Carney DN et al. Prognostic implications of stage of disease and sites of metastases in patients with small cell carcinoma of the lung treated with intensive combination chemotherapy. Am Rev Respir Dis 1981: 123: 500-7.
13. Mountain CF. Prognostic implications of the international staging system for lung cancer. Semin Oncol 1988; 15: 236-45.
14. Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-81.
15. Breslow N. Covariance analysis of censored survival data. Biometrics 1974; 30: 89-90.
16. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966; 50: 163-70.
17. Cox DR. Regression models and life tables. J R Stat Soc 1972; B34: 185-220.
18. Osterlind K, Hansen HH, Hansen M et al. Long term disease free survival in small cell carcinoma of the lung: A study of clinical determinants. J Clin Oncol 1986; 4: 1307-13.
19. Arriagada R, The H, Le Chevalier T et al. Limited small cell lung cancer: Possible prognostic impact of initial chemotherapy doses. Bull Cancer 1989; 76: 605-15.
20. Spiegelman D, Maurer LH, Ware JH et al. Prognostic factors in small cell carcinoma of the lung: An analysis of 1,521 patients. J Clin Oncol 1989; 7: 344-54.
21. Souhami R, Law K. Longevity in small cell lung cancer. A report to the Lung Cancer Subcommittee of the United Kingdom Coordinating Committe for Cancer Research. Br J Cancer 1990; 61: 584-9.
22. Shepherd FA, Evans WK, Feld R et al. Adjuvant chemotherapy following surgical resection for small cell carcinoma of the lung. J Clin Oncol 1988; 6: 1161-9.
23. Wolf M, Holle R, Hans K et al. Analysis of prognostic factors in 766 patients with small cell lung cancer (SCLC): The role of sex as a predictor of survival. Br J Cancer 1991; 63: 986-92.
24. Bergman B, Sullivan M, Sörenson S. Quality of life during chemotherapy for small cell lung cancer. Acta Oncol 1991; 30: 947-57.
25. Cohen MH, Makuch R, Johnston A et al. Laboratory parameters as an alternative to performance status in prognostic stratification of patients with small cell lung cancer. Cancer Treat Rep 1981; 65: 187-95.
26. Suga J, Saijo N, Shinkai T et al. Long teiin survival in patients with small cell lung cancer. Jpn J Clin Oncol 1986: 16: 309-15.
27. Albain KS, Crowley JJ, LeBlanc M et al. Determinants of improved outcome in small-cell lung cancer: An analysis of the 2,580 patients Southwest Oncology Group data base. J Clin Oncol 1990; 8: 1563-74.
28. Rawson NS, Peto J. An overview of prognostic factors in small-cell lung cancer. A report from the Subcommitte for the Management of Lung Cancer of the United Kingdom Coordinating Committe on Cancer Research. Br J Cancer 1990; 61: 597-604.
29. List AF, Hainsworth JD, Davis BW et al. The syndrome of inappropiate secretion of antidiuretic hormone (SIADH) in small cell lung cancer. J Clin Oncol 1986; 4: 1191-8.
30. De Wet M, Falkson G, Rapoport BL. Small-cell lung cancer: Analysis of factors influencing the response to treatment and survival. Oncology 1994; 51: 523-34.
31. Prasad US, Naylor AR, Walker WS et al. Long term survival after pulmonary resection for small-cell carcinoma of the lung. Thorax 1989; 44: 784-7.
32. Shepherd FA, Ginsberg RJ, Feld R et al. Surgical treatment for limited small-cell lung cancer. The University of Toronto Lung Oncology Group experience. J Thorac Cardiovasc Surg 1991; 101: 385-93.
33. O'Connell JP, Kris MG, Gralla RJ et al. Frequency and prognostic importance of pretreatment clinical characteristics in patiens with advanced non-small-cell lung cancer treated with combination chemotherapy. J Clin Oncol 1986; 4: 1604-14.
34. Sagman U, Maki E, Evans WK et al. Small-cell carcinoma of the lung: Derivation of a prognostic staging system. J Clin Oncol 1991: 9: 1639-49.
35. Feliu J, González Barón M, Artal A et al. Bone marrow examination in small-cell lung cancer. When is it indicate? Acta Oncol 1991; 30: 587-91.
36. Castellino RA, De la Paz RL, Larson SM. Imaging techniques in cancer. In De Vita VT, Hellman S, Rosenberg SA (eds): Cancer: Principles and Practice of Oncology, 4th ed. Philadelphia: Lippincott Company 1994; 507.
37. Allan SG, Stewart ME, Love S et al. Prognosis at presentation of small-cell carcinoma of the lung. Eur J Cancer 1990; 26: 703-5.
38. Hainsworth JD, Workman R, Greco FA. Management of the syndrome of inappropriate antidiuretic hormone secretion in small cell lung cancer. Cancer 1983; 51: 161-5.
39. Carney DN, Zweig MH, Ihde DC et al. Elevated serum creatine kinase BB levels in patients with small-cell lung cancer. Cancer Res 1984; 44: 5399-403.
40. Jebb SA, Osborne RJ, Dixon AK et al. Measurements of resting energy expenditure and body composition before and after treatment of small-cell lung cancer. Ann Oncol 1994; 5: 915-9.
41. Ascensao JL, Oken MM, Ewin SL et al. Leukocytosis and large cell lung cancer: A frequent association. Cancer 1987; 60: 903-5.
42. Moley JF, Morrison SD, Gornschboty DM et al. Body composition changes in rats with experimental cancer caquexia: Improvement with exogenous insulin. Cancer Res 1988; 48: 2784-7.
43. Bodey GP. Infection in cancer patients: A continuing association. Am J Med 1986; 81 (Suppl 1A): 11-26.
44. Padfield PL, Morton JJ, Brown P. Production of arginine vasopressin in the syndrome of diuretic hormone excess associated with bronchogenic carcinoma. Am J Med 1976; 61: 825-9.